Table 4.
Year 1-Baseline | Sample Size (n) | β Estimate per Allele | SE | P |
Weight, kga | 2568 | 0.1234 | 0.0529 | 0.020 |
BMI, kg/m2a | 2568 | 0.0461 | 0.0190 | 0.015 |
Waist circumference, cma | 2568 | 0.0754 | 0.0593 | 0.204 |
FI, μU/mL, ln | 2568 | 0.0130 | 0.0043 | 0.002 |
Fasting glucose, mg/dL, lna | 2568 | 0.0003 | 0.0009 | 0.722 |
ISI, lnb | 2506 | −0.0136 | 0.0047 | 0.004 |
Systolic blood pressure, mm Hg | 2568 | −0.0874 | 0.1134 | 0.441 |
Diastolic blood pressure, mm Hg | 2568 | 0.0277 | 0.0740 | 0.708 |
HDL-cholesterol, mg/dL | 2559 | 0.0043 | 0.0591 | 0.942 |
LDL-cholesterol, mg/dL | 2559 | 0.0067 | 0.2033 | 0.974 |
Triglycerides, mg/dL, ln + | 2559 | 0.0047 | 0.0033 | 0.154 |
ALT, U/L, ln+ | 1857 | 0.0801 | 0.1211 | 0.509 |
Visceral adipose tissue, cm2, L4-5 | 618 | −0.0006 | 0.0017 | 0.721 |
Subcutaneous adipose tissue, cm2, L4-5 | 618 | 0.4760 | 1.0300 | 0.644 |
All measures adjusted for baseline value, age at randomization, sex and self-reported race/ethnicity, waist circumference and treatment group except where indicated.
Abbreviation: FI, fasting insulin.
Adjusted for age at randomization, sex, and race/ethnicity
ln (Year 1 measurement) - ln (Baseline measurement)